Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Cardiac Transthyretin Amyloid (ATTR) Fellowship
    Release Date:
    Partner: International Society of Amyloidosis
    Review Process: Expert Review Panel
    Fellowship Rare Disease All
    Clinical Diagnosis and Management of Endometriosis
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Management of Uterine Fibroids
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Rapid Education on Drug-Drug Interactions in COVID-19 Outpatient Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    2023 Global Migraine ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Promoting Pain Treatment in Musculoskeletal Pain
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Improve the Treatment Environment for Cancer Pain Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    LMIC Pharmacovigilance Education
    Release Date:
    Review Process: Pfizer Internal
    Education Patient Safety Kenya, Lesotho, Swaziland
    Knowledge Gaps in Managing Obesity and COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)
    Release Date:
    Partner: Merck KGaA, Darmstadt, Germany, EMD Serono
    Review Process: Pfizer Internal
    Education Oncology All
    Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review process
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac Amyloidosis
    Release Date:
    Partner: National Medical Association
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease USA